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ABSTRACT: The use of extracorporeal cardiopulmonary resuscitation (E- CPR) for the treatment of patients with out- of- hospital 
cardiac arrest who do not respond to conventional cardiopulmonary resuscitation CPR) has increased significantly in the 
past 10 years, in response to case reports and observational studies reporting encouraging results. However, no randomized 
controlled trials comparing E- CPR with conventional CPR have been published to date. The evidence from systematic reviews 
of the available observational studies is conflicting. The inclusion criteria for published E- CPR studies are variable, but most 
commonly include witnessed arrest, immediate bystander CPR, an initial shockable rhythm, and an estimated time from CPR 
start to establishment of E- CPR (low- flow time) of <60 minutes. A shorter low- flow time has been consistently associated 
with improved survival. In an effort to reduce low- flow times, commencement of E- CPR in the prehospital setting has been 
reported and is currently under investigation. The provision of an E- CPR service, whether hospital based or prehospital, car-
ries considerable cost and technical challenges. Despite increased adoption, many questions remain as to which patients will 
derive the most benefit from E- CPR, when and where to implement E- CPR, optimal post- arrest E- CPR care, and whether this 
complex invasive intervention is cost- effective. Results of ongoing trials are awaited to determine whether E- CPR improves 
survival when compared with conventional CPR.
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Every year, ≈350 000 people in the United States
1 
and 275  000 in Europe2 experience an out- of- 
hospital cardiac arrest (OHCA). Overall survival to 
discharge from OHCA resuscitated with conventional 
cardiopulmonary resuscitation (C- CPR) and advanced 
life support protocols including defibrillation, is reported 
to be between 2% and 15%.1,3 These poor survival rates 
are consistent across geographical locations and have 
had only modest improvement over time.4
In patients with OHCA that is refractory to C- CPR 
and in whom the cause of the OHCA is potentially 
reversible, extracorporeal cardiopulmonary resusci-
tation (E- CPR) can provide a bridge to definitive treat-
ment and recovery. The use of E- CPR has increased 
10- fold in the past 10 years5 and many observational 
studies have shown encouragingly high survival 
rates.6,7 However, no randomized controlled trials of E- 
CPR versus C- CPR have been published to date, thus 
the benefits of E- CPR over C- CPR remain unproven. 
This review examines the current literature on E- CPR 
for OHCA, including patient selection, implementation 
models, post- arrest care, cost- effectiveness, and effi-
cacy. We also highlight areas of ongoing research on 
E- CPR and potential future developments.
EXTRACORPOREAL MEMBRANE 
OXYGENATION AND E- CPR
Extracorporeal membrane oxygenation (ECMO) is a 
combination of a blood pump and an oxygenator that 
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can be used to support either pulmonary or both pul-
monary and cardiac function (venovenous or venoar-
terial configurations, respectively). E- CPR is used to 
describe the use of venoarterial ECMO in refractory 
cardiac arrest (RCA). The increased adoption of E- CPR 
has been facilitated by the advent of small, portable 
ECMO devices and circuit improvements. Attributable 
to advances in ECMO technology, it is possible to de-
liver either partial or full cardiorespiratory support for 
weeks or months, if required.
An ECMO circuit consists of a centrifugal pump and 
a membrane oxygenator for oxygen delivery, CO2 re-
moval, and temperature management. In E- CPR, ve-
noarterial ECMO is established while cardiopulmonary 
resuscitation (CPR) is ongoing. The drainage (access) 
cannula is placed into the inferior vena cava via the 
femoral vein, and the “return” cannula is inserted into 
the femoral artery to the level of the common iliac ar-
tery (Figure  1). E- CPR for OHCA is usually provided 
as part of a “bundle of care,”8,9 which includes early 
patient transfer to hospital, mechanical CPR to pro-
vide effective CPR during transport, early initiation of 
E- CPR, and early definitive treatment (eg, coronary an-
gioplasty [Figure 2]).
RATIONALE FOR E- CPR
C- CPR either by manual or mechanical chest com-
pression is the mainstay of circulatory support during 
cardiac arrest. However, even with optimal technique, 
C- CPR delivers only 15% to 25% of normal cardiac 
output10 (or a cardiac index of ≈0.6  L/min per m2)11 
with consequent rapid development of ischemic 
damage to vital organs (this is commonly referred to 
as a low-flow state). Conversely, E- CPR can provide 
near- normal levels of cerebral and end organ per-
fusion.12 The ability to provide full cerebral and end 
organ blood supply, even for days or weeks, with 
E- CPR has enabled a paradigm shift in cardiac ar-
rest—preservation of the brain while awaiting return of 
spontaneous circulation (ROSC), definitive care, and 
cardiac recovery.
INDICATIONS AND PATIENT 
SELECTION FOR E- CPR
To date, there are no unanimously accepted indications 
for E- CPR. The consensus- based French Ministry of 
Health guidelines13 recommend considering E- CPR 
for RCA when ≥1 of the following conditions are met: 
(1) known reversible cause (eg, drug intoxication or hy-
pothermia), likely to require prolonged life support; (2) 
signs of life during CPR; (3) no- flow (the period of time 
from cardiac arrest to the commencement of CPR) 
and low- flow durations <5 and 100 minutes, respec-
tively; (3) an initial shockable rhythm; and (4) an end- 
tidal CO2 >10 mm Hg. However, these guidelines have 
not been prospectively validated. Moreover, few sub-
sequent studies on E- CPR for OHCA have adopted 
all of these indications and some have adopted none 
of them.14
The inclusion criteria used in many E- CPR studies 
include age 18 to 65 years or 18 to 70 years, witnessed 
RCA, immediate bystander CPR, initial shockable 
rhythm, access to immediate coronary angiography, 
and an anticipated low- flow period (ie, the interval from 
C- CPR commencement to E- CPR) of <60 minutes.8
A systematic review and meta- analysis of 841 
E- CPR–treated patients with OHCA (Debaty et al15) for 
prognostic factors or neurological outcome and sur-
vival demonstrated that an initial shockable rhythm was 
associated with twice the odds (odds ratio [OR], 2.20; 
95% CI, 1.30–3.72) of favorable outcomes (survival 
with good neurological function) than nonshockable 
rhythms. Other factors associated with favorable out-
comes were low- flow duration (54 versus 64 minutes) 
(OR, 0.90; 95% CI, 0.81–0.99 [P=0.04], higher arterial 
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pH (difference, 0.12; 95% CI, 0.03–0.22 [P=0.01], and 
lower serum lactate (difference, −3.52  mmol/L; 95% 
CI, −5.05 to −1.99 [P<0.001]). Bystander CPR was also 
associated with higher summary odds for favorable 
outcome (OR, 2.81; 95% CI 0.95–8.32), although this 
was not statistically significant.
Age has been variably reported as a negative prog-
nostic marker for E- CPR. Goto et  al16 found that age 
older than 70  years was associated with poor out-
comes. However, Yu et al17 found that age older than 
75 years was not predictive of poor outcome if the low- 
flow duration was <60 minutes. Debaty et al15 also did 
not find an association between adverse prognosis and 
advancing age.15 Although age is not currently consid-
ered a contraindication to E- CPR, most studies report a 
median age of patients undergoing E- CPR younger than 
Figure  1. Venoarterial extracorporeal membrane oxygenation (ECMO) using a peripheral 
configuration.
Venous blood (blue) is drained via a cannula positioned at the inferior vena cava to the right atrial junction 
and passes through the extracorporeal membrane where oxygenation and CO2 removal occurs. The 
now oxygenated blood (red) is returned via a “return” cannula position in the common iliac artery or 
descending aorta. The distal perfusion catheter, applied after ECMO support is established, is inserted 
into the superficial femoral artery distal to the insertion point of the femoral return cannula, and it supplies 
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60 years14—lower than the median age of 64 years re-
ported in the largest OHCA registries on adult OHCA.18
Other common inclusion criteria for E- CPR include 
signs of life and end- tidal CO2 level >10 mm Hg on arrival 
to the emergency department.7,19 Their value as inclusion 
criteria in E- CPR is yet to be systematically assessed.
WHEN SHOULD THE TRANSITION TO 
E- CPR OCCUR?
The optimal time point to transition from C- CPR to E- 
CPR strategy is yet to be determined. Implementation 
of E- CPR too early may unnecessarily expose patients 
with C- CPR in whom ROSC may potentially occur 
to an expensive procedure with significant additional 
risks, whereas delaying E- CPR implementation may 
jeopardize the potential benefit from the intervention by 
increasing the risk of critical brain and end organ injury 
from prolonged hypoperfusion.
After more than 35 minutes of C- CPR without sub-
sequent E- CPR, <1% of patients with OHCA overall 
will have spontaneous ROSC and survive with a fa-
vorable neurological outcome.20 Therefore the deci-
sion to commence E- CPR needs to occur before this 
point. In an analysis of North American emergency 
medical services (EMS) data,21 transport to an E- CPR 
center between 8 to 24 minutes of EMS resuscitation 
had the highest sensitivity and specificity for favorable 
outcome, with 16  minutes being the optimal time.21 
In a retrospective Korean propensity- matched anal-
ysis (444 patients with C- CPR and 55 patients with 
E- CPR), Kim et  al22 reported that E- CPR outcomes 
became superior to C- CPR after 21  minutes of re-
suscitation. Additionally, E- CPR was associated with 
improved neurologically intact survival from RCA (21% 
versus 0% for 41–60 minutes of C- CPR). These data 
suggest that E- CPR may be considered after 10 to 
20 minutes of unsuccessful C- CPR8,23 in selected pa-
tients.8,24 This, however, presents significant logistical 
challenges. In order to meet these targets, EMS teams 
may need to alter their protocols to facilitate shorter 
on- scene times and adopt mechanical C- CPR to fa-
cilitate effective CPR during transportation, ie, moving 
from a “stay and treat” to a “load and go” strategy. An 
alternative is implementation of E- CPR at the site of 
the cardiac arrest—prehospital E-CPR—which is dis-
cussed below. Any of these options would represent 
a major change for many EMS systems.
E- CPR VERSUS C- CPR
While no published randomized control trials of E- 
CPR versus C- CPR have been published to date, a 
small number of propensity- matched observational 
studies have been completed. In a study of 162 
adult patients (E- CPR=53, C- CPR=109)25 with wit-
nessed cardiac arrest of cardiac origin who had un-
dergone CPR for longer than 20 minutes, the intact 
Figure 2. Key steps in extracorporeal cardiopulmonary resuscitation (E- CPR) for out- of- hospital cardiac arrest (OHCA).8,9
Key initial cardiac arrest variables of witnessed arrest, immediate bystander cardiopulmonary resuscitation (CPR) and shockable 
rhythm are currently required to qualify for a potential E- CPR–eligible OHCA in most trials and services. If the arrest is refractory8,9 to 
advanced life support measures and E- CPR is available at a nearby hospital, the patient is transferred to the nearest E- CPR–capable 
hospital. Many services utilize mechanical CPR to enable ongoing chest compression during transfer. Prearrival notification to the 
accepting hospital by emergency medical services (EMS) is often made. On arrival to the hospital, cannulation, establishment of 
extracorporeal membrane oxygenation, and subsequent definitive treatment of the underlying cause of the arrest is made. Standard 
postcardiac arrest care is implemented in the intensive care unit (ICU). *End- tidal CO2 (ETCO2) and lactate (on arrival to hospital) are 
variably used as inclusion criteria. $Varying definitions of when an arrest becomes “refractory” exist including no return of spontaneous 
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survival rate was higher in the E- CPR group than 
in the propensity- matched C- CPR group (29.2% 
[7/24] versus 8.3% [2/24], log- rank P=0.018). The 
Save- J (Study of Advanced Cardiac Life Support for 
Ventricular Fibrillation With Extracorporeal Circulation 
in Japan)26 prospectively compared E- CPR and C- 
CPR outcomes in 454 patients with OHCA who had 
an initial shockable rhythm and no ROSC until at least 
15  minutes after arrival to the hospital. Favorable 
neurological outcome at 6 months was found in 29 
of 260 patients with E- CPR (11.2%) versus 5 of 194 
patients (2.6%) in the C- CPR group (P=0.001).
Most recently, a large Parisian registry27 compared 
C- CPR– and E- CPR–treated patients with OHCA. 
Overall survival was 8.4% in 525 patients treated with 
E- CPR and 8.6% in 12 666 patients treated with C- 
CPR (P=0.91). After multivariable regression analysis, 
the provision of E- CPR was not associated with in-
creased survival (OR, 1.3; 95% CI, 0.8–2.1 [P=0.24]). 
A propensity score–matched analysis of 429 pairs 
for survival adjusted for major confounders did not 
find a significant difference in survival between the 
C- CPR and E- CPR groups (OR, 0.8; 95% CI, 0.5–
1.3 [P=0.41]). However, despite the large size of that 
study, several limitations exist. First, there was no 
specific time to transition to E- CPR strategy nor strict 
inclusion criteria for E- CPR. This resulted in only 27% 
of patients having a shockable rhythm and 39% of E- 
CPR–treated patients receiving CPR for over 90 min-
utes. Further, E- CPR was initiated at the discretion of 
treating clinicians, thereby introducing selection bias 
by known or unknown confounders, which may not 
have been corrected for in propensity and regression 
analysis.
Bartos et  al28 retrospectively compared 160 con-
secutive patients with OHCA with refractory ventricular 
tachycardia/ventricular fibrillation treated with E- CPR 
as per predefined University of Minnesota protocol29 
with 654 patients who received standard CPR as part 
of the Amiodarone, Lidocaine or Placebo in Out- of- 
Hospital Cardiac Arrest Study (ALPS)30 using multivari-
able analysis. Despite E- CPR–treated patients having 
longer mean duration of CPR (60 versus 35 minutes, 
P<0.001), the E- CPR cohort was associated with 
better neurological outcomes at all CPR durations 
<60 minutes (33% E- CPR group versus 23%, P=0.01). 
No patients treated with C- CPR survived if their period 
of resuscitation was >40 minutes compared with 25% 
(9/26) in the E- CPR group.
While some systematic reviews and meta- analyses 
suggested that E- CPR may improve survival or neuro-
logical outcome,31–36 the most recent and comprehen-
sive systematic review from Holmberg et  al14 yielded 
mixed results. This review included 12 studies on 
adult OHCA reporting survival to discharge. Of these, 
7 showed higher odds of survival with E- CPR versus 
C- CPR, while 5 showed lower odds. Among 8 studies 
reporting survival with good neurological outcome, 7 
favored E- CPR. A meta- analysis was not performed 
because of high study heterogeneity.
All systematic reviews of E- CPR have rated the 
quality of evidence as very low. The inability of the 
available reviews to draw consistent strong conclu-
sions on E- CPR for OHCA is a direct result of sig-
nificant limitations of the individual studies reviewed. 
Most reviewed studies were small, single- center, and 
from diverse locations with different EMS systems, 
all of which limit the quality of the comparative data. 
Furthermore, inclusion criteria for E- CPR differ be-
tween studies, and other unmeasured confounders 
may limit the internal and external validity of re-
sults. Finally, several E- CPR studies have assessed 
a bundle of care that includes expedited transport 
to hospital, mechanical CPR, and immediate coro-
nary angiography. While these have not been shown 
to be convincingly beneficial in their respective own 
right,37–39 it is possible that a whole E- CPR “bun-
dle” contributes more to outcomes than E- CPR in 
isolation.
Based on the low quality of the current E- CPR lit-
erature, in its recent Focused Update on Advanced 
Cardiovascular Life Support,40 the American Heart 
Association concluded that there was insufficient ev-
idence to recommend the routine use of E- CPR but 
that it should be considered as rescue therapy for se-
lected patients when it can be rapidly implemented 
and supported by skilled providers (class 2b, level of 
evidence C).
Prehospital E- CPR
Implementation of E- CPR at the cardiac arrest scene 
could potentially decrease the time to E- CPR initiation. 
In a cohort study from Paris,19 two periods of differ-
ent E- CPR management strategies were compared. 
The first period (n=114 patients) included a mandatory 
30- minute interval of C- CPR before either transport to 
hospital (if within 20 minutes range) or initiation of pre-
hospital E- CPR. With this strategy, low- flow duration 
was 93±27 minutes, with 8% neurologically intact sur-
vival. In the second period (n=42 patients), a more ag-
gressive prehospital E- CPR strategy and more defined 
inclusion criteria were implemented, with a dedicated 
on- call E- CPR team that was dispatched to all patients 
with OHCA younger than 70 years. Attempts to perform 
E- CPR commenced after 20  minutes of unsuccess-
ful C- CPR, with the aim of initiating pump flow within 
60 minutes from the onset of cardiac arrest. After the 
implementation of this strategy, the mean low- flow in-
terval was reduced by 20  minutes and neurologically 
intact survival improved to 29% (21% absolute increase, 
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cohorts, prehospital E- CPR was associated with sig-
nificantly reduced low- flow duration and higher rates 
of ROSC compared with hospital- based E- CPR, even 
if it was not an independent predictor of survival to 
discharge.
There are several prospective studies (either in 
progress or planned) to assess the feasibility and effi-
cacy of prehospital E- CPR. For example, the London 
Sub 30 (Feasibility Study of a Pre- Hospital Extra- 
Corporeal Membrane Oxygenation (ECMO) Capable 
Advanced Resuscitation Team at Achieving Blood 
Flow Within 30 Minutes in Patients With Refractory 
Cardiac Arrest) study (NCT03700125)19 will attempt 
to establish E- CPR within 30  minutes of OHCA 
using mobile prehospital E- CPR teams in London. 
The ongoing Paris APACAR2 (A Comparative 
Study Between a Pre- hospital and an In- hospital 
Circulatory Support Strategy (ECMO) in Refractory 
Cardiac Arrest) (NCT02527031)41 is randomizing 
patients with OHCA to receive either prehospital or 
hospital E- CPR, depending on their location and 
predicted transport time to hospital. Patients with 
prehospital E- CPR will receive E- CPR between 20 
and 30  minutes of C- CPR. Participants random-
ized to hospital- based E- CPR will be transferred to 
the hospital with mechanical CPR. Selection crite-
ria include no- flow duration <5  minutes, age 18 to 
65 years, refractory arrest (defined as 20 minutes of 
C- CPR), and either shockable rhythm or signs of life 
during resuscitation.
POST–E- CPR RESUSCITATION CARE
Intensive care management of patients with E- CPR 
is complex and involves a multidisciplinary approach. 
There are few data on how patients with E- CPR 
should be managed, and conventional postarrest 
protocols are generally utilized. The optimal man-
agement of arterial oxygen (partial pressure of O2) 
and CO2 (partial pressure of CO2) post- OHCA has 
not been identified in patients with C- CPR or patients 
with E- CPR. Arterial hyperoxia is common postcar-
diac arrest (with or without E- CPR) and has been 
associated with unfavorable outcomes in some ob-
servational C- CPR studies.42–44
Following the initiation of other forms of ECMO, a 
rapid reduction in partial pressure of CO2 has been 
associated with adverse neurological outcomes.45 It 
has been postulated that this could be caused by an 
acute reduction in cerebral blood flow.45 However, 
in a randomized study46 of patients with C- CPR and 
ROSC comparing low- normal versus high- normal 
partial pressure of CO2 and normoxia versus mod-
erate hyperoxia, no significant difference in levels 
of neurological biomarkers was found.46 This study 
was underpowered to identify differences in clinical 
outcomes.
The randomized controlled trials of reduction of ox-
ygen administration to target an oxygen saturation of 
90% to 94%, compared with 98% to 100%, as soon 
as feasible following successful resuscitation from 
OHCA (EXACT [Reduction of Oxygen After Cardiac 
Arrest trial]—NCT03138005) and of oxygen manage-
ment in patients with ECMO (BLENDER [Blend to Limit 
Oxygen in ECMO: A Randomised Controlled Registry 
Trial]—NCT03841084), comparing clinical outcomes 
in patients with ECMO randomized to receive either 
100% oxygen to the oxygenator versus a restrictive 
strategy, as well as the upcoming TAME [Targeted 
Therapeutic Mild Hypercapnia After Resuscitated 
Cardiac Arrest] study (NCT03114033) comparing mild 
hypercapnia versus normocapnia in C- CPR OHCA, 
may help guide future CO2 and oxygen management.
In patients undergoing E- CPR, systemic antico-
agulation is required to prevent thrombotic compli-
cations from the patient–circuit interface. However, 
this increases the risk of bleeding, and in patients 
with E- CPR, significant bleeding has been reported 
in up to 70% of cases and is associated with worse 
outcomes.47 Unfractionated heparin is the most 
commonly used anticoagulant during ECMO. This 
is routinely monitored using either activated clot-
ting time, partial thromboplastin time, or anti- Xa 
activity, the former 2 of which can be measured as 
point- of- care tests.48,49 More recently, thromboelas-
tography and thromboelastometry (rotational throm-
boelastometry) have been investigated as alternative 
tests for monitoring anticoagulation during ECMO. 
Unlike activated partial thromboplastin time, which 
is plasma- based, rotational thromboelastometry and 
thromboelastography are point- of- care viscoelastic 
tests that assess multiple coagulation functions in 
whole blood, including platelet function, fibrinogen 
function, and fibrinolysis. Preliminary evidence in-
dicates that viscoelastic tests are feasible for an-
ticoagulation management during extracorporeal 
circulation and are associated with reduced hep-
arin consumption compared with activated partial 
thromboplastin time–based protocols.50 Thrombin 
inhibitors (such as bivalirudin) are mainly used when 
heparin is contraindicated or, as low antithrombin 
3 levels are common on ECMO,51 in heparin resis-
tance and may enable more tightly controlled anti-
coagulation52 in patients undergoing extracorporeal 
circulation.
COST- EFFECTIVENESS OF E- CPR
Significant training, skill, equipment, and expense is 
required to provide an effective E- CPR service. Three 
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Japan (Table S1) reported that E- CPR was within ac-
cepted cost thresholds for advanced medical inter-
ventions.53–55 These costs ranged between $16  000 
to $52  000/quality- adjusted life- years, depending on 
geographical location. E- CPR may be cost- effective 
for several reasons; patients with E- CPR are gen-
erally younger than patients with C- CPR and have 
good neurological outcomes with minimal residual 
disabilities and long- life expectancy postevent. In 
these studies, however, the maximum follow- up pe-
riod was only 1  year,55 and long- term outcome data 
are needed in future cost- effectiveness analyses. The 
cost- effectiveness of a prehospital E- CPR strategy is 
unknown.
The rates of death by neurological criteria in pa-
tients resuscitated with E- CPR are ≈3 times higher 
than in those resuscitated with C- CPR, resulting in 
an increased potential for organ donation.56,57 As of 
yet, the potential for increased organ donation has 
not been considered in cost- effectiveness model-
ling of E- CPR programs and presents some ethical 
questions.
Table. Upcoming Randomized Controlled Trials on E- CPR
Trial Name and Registration Number
Sample 




Standard arm: standard treatment as per 
ERC guidelines. 
Intervention: preclinical resuscitation 
by EMS and transport to the ED with 
ongoing mechanical cardiopulmonary 





• Initial rhythm of ventricular fibrillation or ventricular 
tachycardia when external defibrillation administered
• Bystander CPR
• No ROSC within 15 min of C-CPR
July 2021
EROCA (NCT03065647)63 
Standard arm: BLS and ACLS by EMS 
per existing protocols at the scene of the 
cardiac arrest. 
Intervention arm: patients with OHCA 
refractory to initial BLS and ACLS will 
be transported by EMS with ongoing 
mechanical CPR and ACLS to an ED 





• OHCA of presumed nontraumatic cause
• Predicted arrival time at E-CPR–capable hospital 
within 1 h
• Witnessed arrest or initial shockable rhythm




Prague OHCA Study (NCT01511666)64 
Standard arm: patients in the standard 
arm will be further managed as per ERC 
guidelines. Coronary angiography will 
be performed only if indicated according 
to routine practice, and mild therapeutic 
hypothermia will be instituted as soon as 
possible as per guidelines. 
Intervention arm: (hyperinvasive) 
immediate institution of a mechanical 
chest compression device and prehospital 
intra- arrest cooling by RhinoChill device 
(BeneChill). Directly transferred to cardiac 
center catheterization laboratory under 
continuous CPR. After admission to 
cardiac catheterization laboratory for 





• Witnessed OHCA of presumed cardiac cause
• Minimum of 5 min of advanced life support 
performed by emergency medical team without 
sustained ROSC





Patients with refractory OHCA—defined 
by the failure of EMS to resuscitate at the 
20th min of cardiac arrest with a minimum 
of 3 automatic external defibrillations or 
equivalent analysis will be randomized 
to prehospital arm: E- CPR in prehospital 
setting—implementation of E- CPR support 
at site of cardiac arrest and then transfer 
to hospital; or in- hospital arm: transfer 
to hospital for E- CPR implementation in 
hospital setting
210 Paris, France • Adults older than 18 y and those younger than 65 y 
• Refractory cardiac arrest (defined by the failure of 
professionals to resuscitate at the 20th min of cardiac 
arrest with a minimum of 3 defibrillator shocks
• Beginning of C-CPR within the first 5 min after 
cardiac arrest (no-flow duration <5 min) with 
shockable rhythm or the presence of signs of life 
during resuscitation (any rhythm)
• Medical cause of the cardiac arrest
• End-tidal CO2 >10 mm Hg at the time of inclusion
• Absence of major comorbidities and E-CPR team 
available on-site within 40 min of cardiac arrest
March 2020
ACLS indicates advanced cardiac life support; APACAR2, A Comparative Study Between a Pre- hospital and an In- hospital Circulatory Support Strategy 
(ECMO) in Refractory Cardiac Arrest; BLS, basic life support; CPR, cardiopulmonary resuscitation; C- CPR, conventional cardiopulmonary resuscitation; E- 
CPR, extracorporeal cardiopulmonary resuscitation; ED, emergency department; EMS, emergency medical services; ERC, European Resuscitation Council; 
EROCA, E- CPR for Refractory Out- Of- Hospital Cardiac Arrest; INCEPTION, Early Initiation of Extracorporeal Life Support in Refractory OHCA; OHCA, out- of- 
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FUTURE DIRECTIONS OF E- CPR
Using most commonly used inclusion criteria (ie, 
aged 18 to 65 years, witnessed cardiac arrest, CPR 
started within 10 minutes, absence of asystole as the 
first cardiac rhythm on EMS arrival), it is estimated 
that only 4% to 11%58–60 of all patients with OHCA 
would be potentially eligible for E- CPR.60 The rela-
tive infrequency of RCAs meeting current E- CPR in-
clusion criteria (even in tertiary referral centers)27,59,60 
inherently limits large sample cohorts and therefore 
the ability to accurately plan recruitment timelines. 
Moreover, given the known poor outcomes with ex-
tended C- CPR, with neurologically intact outcomes 
of <1% at ≈35 to 40  minutes,20,61 some clinicians 
have raised ethical concerns regarding randomiza-
tion of patients to continued C- CPR (when it may 
already be deemed to have failed) and E- CPR is 
available. However, a small number of randomized 
controlled trials are currently comparing E- CPR with 
C- CPR (Table).62–65
Although difficult to conduct, large- scale multi-
center studies of E- CPR are needed to address the 
significant uncertainties regarding efficacy, case 
selection, timing, and prognostic markers versus 
C- CPR. In future studies, standardized definitions 
of key variables including what constitutes an RCA 
and CPR duration or arrest to ECMO flow times is 
required to enable more robust comparisons of out-
comes. Moreover, documentation and adjustment 
for other known prognostic variables including pre-
cardiac arrest performance status and intracardiac 
arrest variables (eg, end- tidal CO2, lactate, pH, and 
potassium) is required.14
An initial shockable rhythm is a common entry 
criterion for most E- CPR programs. This is present 
in only about one third of OHCA cases66 and has 
a significantly better outcome than nonshockable 
rhythms. However, it is possible that patients with 
initial nonshockable rhythms may also benefit from 
E- CPR if other favorable prognostic markers are 
present.67
Should E- CPR be proven to improve survival in se-
lected patients with OHCA, there would be significant 
organizational and economic implications for health 
systems to ensure optimal equity of access.
High- volume venovenous ECMO centers have 
better outcomes than low- volume centers.68 Given 
the high complexity of patients with E- CPR, manag-
ing them in major centers with significant experience 
is reasonable. A composite model of having hospital 
centers that establish E- CPR support, then transfer the 
patient to a larger center for continued care, has been 
proposed in a “hub and spoke”–type format. However, 
this model is yet to be tested in any large- scale set-
tings and may require additional resources to facilitate 
the transfer of critically unwell patients with E- CPR be-
tween locations.
CONCLUSIONS
E- CPR for refractory OHCA may improve outcomes 
in carefully selected patients. However, the evidence 
base for E- CPR efficacy, patient selection, and post-
cardiac arrest management is poor. Much work is 
needed in this area and large- scale high- quality trials, 
although challenging, should be made a priority.
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Table S1. Summary of E-CPR cost effectiveness studies. 
*
Cost per survivor calculated as total hospital cost of all patients divided by number of survivors
Location Pt No. 
Cost per ECPR patient (USD) to 
hospital discharge or death 
Cost per survivor* Cost per QALY ICER per QALY 
Bharmal et al56 North America 32 $125,683 (IQR $49,751-$206,341) NA $56,156 NA 
Dennis et al54 Australia 62 $52,615 (SD $53, 016) $88,167 NA $17,648 
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